Physician profile

Reeta M Arora

Physical Medicine & Rehabilitation · Portsmouth, VA

NPI 1689763476

$634.05

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

See the full distribution for Physical Medicine & Rehabilitation

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$120.44

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $188.42 2020-2023 Lite Plate System
Abbott Laboratories $136.56 2021-2024 Proclaim
Pfizer INC. $91.90 2019-2020
Amgen INC. $86.36 2019-2022
Supernus Pharmaceuticals, INC. $82.29 2019
Zyla Life Sciences, INC. $21.74 2019
Depuy Synthes Sales INC. $17.67 2020
Electronic Waveform Lab, INC. $9.11 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Reeta M Arora

$634.05

in general payments reported 2019-2025

Years
2019-2024
Top company
Stryker Corporation

https://glasscript.com/doctor/258390/reeta-m-arora

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.